Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
38
NCT02354261
Open-label Trial of SUBA™-Itraconazole (SUBA-Cap) in Subjects With Basal Cell Carcinoma Nevus Syndrome (BCCNS)
Phase: Phase 2
Role: Lead Sponsor
Start: Aug 7, 2015
Completion: Mar 31, 2019